Jefferies Has Buy Rating On Teleflex (TFX)

Jefferies & Co. has a Buy rating and a $63 price target on shares of Teleflex TFX. In a note sent to clients, Jefferies writes, "With pure-play status on the horizon, TFX's shares deserve an in-line multiple with competing medical device/supply competitors given its already above average FCF yield and numerous initiatives to drive incremental revenue and margin expansion." Shares closed at $55.60 yesterday.